Search

Robert J Natuk

from Raritan, NJ
Age ~68
Get Report
Also known as:
Bob Natuk
Phone and address:
63 Vones Ln, Raritan, NJ 08869
(908) 231-1499
Related to:
Larry GerczakJulie B Gerczak, 64Charles M Kolvites, 93Kevin J Kolvites, 61Kathleen G Kolvites, 68Wilda M KolvitesCharles I Kolvites, 66Ann Marie Gerczak, 61
Connected to:
Mark W Natural, 33Adolfo Natusch, 48Fred V Natusch, 53Alisha K Natvig, 39Connie B Natvig, 60Gregory R Natvig, 62Paul W Natvig, 61Brian J Natwick, 49John F Natwick, 111Vernon R Natwick, 89

Robert Natuk Phones & Addresses

  • 63 Vones Ln, Raritan, NJ 08869 (908) 231-1499
  • Frenchtown, NJ
  • Warrington, PA
  • Worcester, MA
  • 63 Vones Ln, Raritan, NJ 08869 (908) 305-0808

Work

Company: Pel-freez biologicals Jan 2018 Position: Director of strategic partnerships

Education

School / High School: University of Massachusetts Medical School 1984 to 1987

Emails

r***[email protected]

Resumes

Resumes

Robert Natuk Photo 1

Director Of Strategic Partnerships

View page
Location:
63 Vones Ln, Raritan, NJ 08869
Work:
Pel-Freez Biologicals
Director of Strategic Partnerships
Pel-Freez Biologicals
Consultant
Education:
University of Massachusetts Medical School 1984 - 1987

Business Records

Name / Title
Company / Classification
Phones & Addresses
Robert Natuk
Principal
Barley Sheaf
Whol Grain/Field Beans
63 Vones Ln, Raritan, NJ 08869

Publications

Us Patents

Method Of Enhancing Immune Responses To Herpes

View page
US Patent:
6867000, Mar 15, 2005
Filed:
Dec 7, 2000
Appl. No.:
10/169057
Inventors:
Eric M. Mishkin - Monroe NY, US
Robert J. Natuk - Raritan NJ, US
Michael W. Pride - Staten Island NY, US
Maninder K. Sidhu - New City NY, US
Assignee:
Wyeth Holdings Corporation - Madison NJ
International Classification:
C12Q001/68
US Classification:
435 6, 435 691, 4242291, 4242781
Abstract:
A method for inducing and enhancing protective and/or therapeutic immunity in a mammal to HSV includes the steps of at least one immunization with an effective amount of a DNA vaccine composition which comprises a first nucleic acid molecule comprising a DNA sequence encoding the HSV type 1 or type 2 gD protein, and a second nucleic acid molecule comprising a DNA sequence encoding each Interleukin-12 heterodimer subunit. The method also comprises at least one subsequent immunization with an effective amount of a protein vaccine composition which comprises the HSV type 1 or type 2 gD protein; and the IL-12 heterodimer. A local anesthetic may be included in the DNA vaccine composition in an amount that forms one or more complexes with the nucleic acid molecules. When provided to the mammal in suitable effective dosages according to this protocol, the vaccine compositions used in this method produce an unexpectedly good protective and/or therapeutic immune response against HSV in an immunized mammal.

Recombinant Adenovirus Vaccines

View page
US Patent:
20040170647, Sep 2, 2004
Filed:
Mar 5, 2004
Appl. No.:
10/794876
Inventors:
Alan Davis - Missouri City TX, US
Michael Lubeck - Highland Mills NY, US
Robert Natuk - Raritan NJ, US
Pranab Chanda - West Windsor NJ, US
Shridhara Murthy - Ann Arbor MI, US
Paul Hung - Bryn Mawr PA, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K048/00
A61K039/12
US Classification:
424/199100, 424/093200
Abstract:
This invention provides a method of protecting a primate from an infectious organism by stimulating the production of antibodies or cell mediated immunity to the infectious organism which comprises administering to said primate intranasally, intramuscularly, or subcutaneously, live recombinant adenoviruses in which the virion structural protein is unchanged from that in the native adenovirus from which the recombinant adenovirus is produced, and which contain the gene coding for the antigen corresponding to said antibodies or inducing said cell mediated immunity. Preferably, the infectious organism is HIV and the primate is a human.

Attenuated Herpes Simplex Virus Type-2, Vectors Thereof And Immunogenic Compositions Thereof

View page
US Patent:
20080089910, Apr 17, 2008
Filed:
Jun 28, 2005
Appl. No.:
11/630447
Inventors:
Robert Visalli - Columbia City IN, US
Jacek Kowalski - Mahwah NJ, US
Robert Natuk - Raritan NJ, US
Susan Blakeney - Monroe NY, US
International Classification:
A61K 31/70
A61K 39/245
A61P 43/00
C12N 15/00
C12N 5/00
C12N 7/00
C12N 7/04
US Classification:
424231100, 435235100, 435236000, 435320100, 435325000, 514044000
Abstract:
The present invention broadly relates to the attenuation of herpes simplex virus type 2 (HSV-2). More particularly, the invention relates to the identification of mutations in the HSV-2 U24 gene which attenuate the pathogenicity of HSV vectors in mammals and immunogenic compositions thereof.

Methods For Producing An Immune Response Against Hiv-1

View page
US Patent:
6511845, Jan 28, 2003
Filed:
Jul 18, 2000
Appl. No.:
09/618360
Inventors:
Alan R. Davis - Missouri City TX, 77459
Paul P. Hung - Bryn Mawr PA, 19010
Michael D. Lubeck - York PA, 17402
Robert J. Natuk - Raritan NJ, 08869
Pranab K. Chanda - West Windsor NJ, 08550
Shridhara C. S. Murthy - Ann Arbor MI, 48105
International Classification:
A61K 3921
US Classification:
4353201, 424 931, 424 961, 4242081, 4242331, 4241991, 435 691
Abstract:
This invention provides a method of protecting a primate from an infectious organism by stimulating the production of antibodies or cell mediated immunity to the infectious organism which comprises administering to said primate intranasally, intramuscularly, or subcutaneously, live recombinant adenoviruses in which the virion structural protein is unchanged from that in the native adenovirus from which the recombinant adenovirus is produced, and which contain the gene coding for the antigen corresponding to said antibodies or inducing said cell mediated immunity. Preferably, the infectious organism is HIV and the primate is a human.
Control profile
Robert J Natuk from Raritan, NJ, age ~68 Get Report